[1]
P. Chotenoparatpat, “Comparison of Original and Generic Enoxaparin for Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: a Randomized Double Blind Controlled Trial)”, Vajira Med J, vol. 56, no. 2, Jan. 2015.